Achaogen Priced, Nasdaq: AKAO
Developing antibiotic treatments of multi-drug resistant infections.
Industry: Health Care
First Day Return: +19.2%
AKAO
Developing antibiotic treatments of multi-drug resistant infections.
| IPO Data | |
|---|---|
| IPO Date | 03/11/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $72 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | South San Francisco, CA, United States |
| Founded | 2002 |
| Employees at IPO | 39 |
| Website www.achaogen.com | |
IPO News for Achaogen
Achaogen (AKAO) Performance
